Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines (Q57559188)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Teresa Auguet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Fatima Sabench

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Salome Martinez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Daniel Del Castillo

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Daniel Del Castillo

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Isabel Quesada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Carmen Aguilar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Anna Maria Luna

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mercé Hernández

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

José Antonio Porras

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Anna Lucas

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Silvia Pellitero

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jordi Llutart

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Cristóbal Richart

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

published in

Clinical Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

691-698

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

Adipose tissue, inflammation and atherosclerosis

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Inflammation, a link between obesity and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Adipose tissue dysfunction in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Effect of exercise training on plasma visfatin and eotaxin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Use and abuse of HOMA modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Anti-inflammatory Profile of FTO Gene Expression in Adipose Tissues From Morbidly Obese Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Medicine. Visfatin: a new adipokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 pre-adipocytes and adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

Molecular Characteristics of Serum Visfatin and Differential Detection by Immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04327.X

10.1111/J.1365-2265.2011.04327.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22182404%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference